We should hopefully get an update in Aug when they announce results.
i believe mdr was migrating all their clients across by 2h24 & also there was a potential to get another 5% share of charac if some conditions were met (but this was implementing some of characs software into anz mdr platform so mdr would be paying saas fees to charac).
uk market should improve with Labor being elected & more money going into nhs & presumably pharmacies/medication support as well, but to me one of the best decisions they made....stop burning almost $1m a year in uk & this passive investment gives them a foot in the door if/when this company gets any traction.
their original press release said charac has 450 pharmacies, so this is a small company which is why only $1m for 7.3% stake.....if it works, great, if it doesn't, not a huge cost for shareholders
Add to My Watchlist
What is My Watchlist?
